Background:Treatment of recurrent breast cancer, like treatment early-stage is based on consideration tumor biology and clinical history. Thus, characterization hormonal HER2 status critical for all patients, a detailed assessment past treatment, including timing therapies as well patient symptoms functional assessment, essential. Determination hormone receptor should be repeated in cases first...
